The Correlation of EMMPRIN and EGFR Overexpression toward Muscle Invasiveness in Urothelial Carcinoma of Bladder

Abstract and Figures Urothelial carcinomas represent 90% of all primary bladder cancers. Muscle invasion is a critical prognostic determinant in urothelial carcinoma. The overexpression of EMMPRIN and EGFR was found in urothelial carcinoma. The association between the two markers has not been repor...

全面介紹

Saved in:
書目詳細資料
Main Authors: Leonita Agustin Hambalie, Leonita, Anny Setijo Rahaju, Anny, Gondo Mastutik, Gondo
格式: Article PeerReviewed
語言:English
Indonesian
Indonesian
English
出版: Medico Legal Society
主題:
在線閱讀:https://repository.unair.ac.id/121618/1/C12%20Artikel%20The%20Correlation%20of%20EMMPRIN.pdf
https://repository.unair.ac.id/121618/2/C12%20Etik%20The%20Correlation%20of%20EMMPRIN.pdf
https://repository.unair.ac.id/121618/3/C12%20PAK%201.pdf
https://repository.unair.ac.id/121618/4/C12%20Turnitin%20The%20Correlation%20of%20EMMPRIN.pdf
https://repository.unair.ac.id/121618/
https://medicopublication.com/index.php/ijfmt/article/view/14782/13385
https://doi.org/10.37506/ijfmt.v15i2.14782
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
實物特徵
總結:Abstract and Figures Urothelial carcinomas represent 90% of all primary bladder cancers. Muscle invasion is a critical prognostic determinant in urothelial carcinoma. The overexpression of EMMPRIN and EGFR was found in urothelial carcinoma. The association between the two markers has not been reported in urothelial carcinoma, therefore we aimed to analyze the expression of EMMPRIN and EGFR and investigate their association with urothelial carcinoma invasiveness. Paraffin-embedded tissues were obtained from 54 urothelial carcinoma patients which then underwent immunohistochemistry staining for EMMPRIN and EGFR antibody. The comparison of EMMPRIN and EGFR expression was tested using the Mann Whitney U test. The correlation was analyzed using the Spearman test. Results showed a significant difference of EMMPRIN expression between non-muscle-invasive and muscle-invasive bladder cancer (p = 0.000), and EMMPRIN expression was significantly correlated with the muscle invasion (r s = 0.481, p = 0.000). A significant difference of EGFR expression between the non-muscle-invasive and muscle-invasive bladder cancer was also found (p = 0.020), and EGFR expression was significantly correlated with the muscle invasion (r s = 0.319, p = 0.019). The expression of EMMPRIN was positively correlated with EGFR in urothelial carcinoma (r s = 0.322, p = 0.018). The expression of EMMPRIN and EGFR are two potential biomarkers for urothelial carcinoma invasiveness which may be helpful to differentiate between muscle-invasive and non-muscle-invasive bladder cancer.